Gilead Sciences - Trop-2 ADCs in HER2-negative mBC: Current evidence and future perspectives in 1L mTNBC

Name: Gilead Sciences - Trop-2 ADCs in HER2-negative mBC: Current evidence and future perspectives in 1L mTNBC
Start: 2026-12-06T12:30
End: 2026-12-06T14:00
Location: Suntec Convention Centre

ESMO Asia 2026 · 6 December 2026 · 12:30–14:00 · Hall 401

Gilead Sciences - Trop-2 ADCs in HER2-negative mBC: Current evidence and future perspectives in 1L mTNBC was a session at ESMO Asia 2026 on 6 December 2026 in Singapore, with 2 speakers on record.

Speakers

Hope S. Rugo — Panelist City of Hope Comprehensive Cancer Center
Yoon-Sim Yap — Chair NCCS - National Cancer Centre Singapore